• The enhanced portfolio includes the Scenaria View, Supria series, The Echelon Smart and Arietta series,
• Offering a diverse portfolio, the new range will include solutions pertaining to CT, MRI, Digital Radiography, AI, PACS, endoscopy, IVD and ultrasound systems
• Keeping the patient and their comfort at the core, Fujifilm’s new portfolio to benefit millions of Indians

Image Caption: Shunsuke Honda, Senior Manager Medical System Division, Fujifilm India, Koji Wada, Managing Director Fujifilm India and Chander Shekhar Sibal, Head of Division, Medical Division, Fujifilm India

 Fujifilm India Pvt Ltd, a leader in diagnostic imaging and medical system technology, today unveiled a new range of products at the 74th National Annual Conference of IRIA 2022. The latest portfolio includes a plethora of products offering complete and integrated solutions for diagnostic purposes including CT, MRI, X-ray, AI, PACS, endoscopy and ultrasound systems through the Scenaria View, Supria series, The Echelon Smart and Arietta series

In order to strengthen its market position further and provide a wide variety of diagnostic services, Fujifilm completed the acquisition and takeover of Hitachi’s Diagnostic Imaging on 31 March last year. With the acquisition, Fujifilm offers a comprehensive solution spectrum that caters to a broad range of clinical needs.

Highlights of Fujifilm’s enhanced portfolio include:

• Scenaria View (128 slice CT Solution) is a powerful premium performance CT solution that provides dependable routine application capabilities with available advanced clinical modules for Interventional CT, extended coverage Shuttle Scanning (for Perfusion Exams), Cardiac CTA and Dual Energy examinations. The View employs 64 discrete detector and electronics channels over a 40mm detector coverage and reconstructs up to 128-slices per scan rotation.

• Supria (32/128 CT Solution) is an evolved CT device, employing latest technologies such as whole-body sub-millimeter imaging and dose reduction technologies. It provides lower dose and high-quality images and is capable of imaging in various patient positions reducing the overall scanning burden on patients.
• The Echelon Smart (1.5T Superconductive MRI) is based on Fujifilm’s proprietary technology, and opened the potential for 1.5T systems, providing superb image quality and superior install flexibility, inherited from permanent-magnet MRI systems. It comes with noise reduction technology for a patient-friendly examination.
• The ARIETTA (Series of Ultrasound) is designed to provide high quality imaging across a broad clinical range that includes abdominal, cardiac, and vascular applications. It has been developed with cutting edge technology for enhanced accuracy and safety to transform ultrasound diagnosis.
    
  

Managing Director of Fujifilm India, Mr. Koji Wada said, “Fujifilm has demonstrated the ability to be a leader in technical advancement and scientific innovation through its newest products and services lineup. Now, millions of individuals will have access to the most precise and accurate medical imaging and screening. This is a significant milestone for Fujifilm and its future growth. Today, we are stronger as a team, and our goal is to maximise the patients’ benefits with these new portfolio synergies. In the realm of prevention and diagnostics, our goal is to become a market leader and the number one comprehensive partner for the Indian healthcare community.”

Mr. Chander Shekhar Sibal, Senior Vice President, Medical Division, Fujifilm India said, “As a leader in imaging technologies, we strive to ‘Never Stop’ providing the most cutting-edge technologies and solutions that not only improve image quality and workflow, but also focus on the patient’s overall well-being. Through our new launches, we aim to boost the diagnostic market and empower medical imaging information across the entire healthcare industry, keeping in mind the obstacles that a hospital experiences every day in diagnostics and imaging services.”

Fujifilm India has always worked towards spreading maximum awareness regarding early detection of critical ailments which can otherwise be treated if diagnosed on time. As a conscious effort, the brand has consistently pushed forward to improve healthcare diagnostic standards, helping to make the world better and fitter. Fujifilm India is continually working to innovate and introduce advanced technologies to produce forward-thinking medical equipment. The brand’s efforts have been centered at building a line of medical care that will offer easy access to healthcare solutions to millions of people and in turn strengthen the country’s medical infrastructure. Fujifilm is committed to providing Indians with the most effective diagnostic technologies available. The superior technical and innovative prowess is a testimony to the same, and with each passing year, the brand is striving to further fortify its position as the industry pioneer in medical imaging while still being committed to diagnostic services.